These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 29263108)
1. Evaluation of Protective Efficacy of Selected Immunodominant B-Cell Epitopes within Virulent Surface Proteins of Streptococcus pneumoniae. Papastamatiou T; Routsias JG; Koutsoni O; Dotsika E; Tsakris A; Spoulou V Infect Immun; 2018 Mar; 86(3):. PubMed ID: 29263108 [TBL] [Abstract][Full Text] [Related]
2. Discovery of Immunodominant B Cell Epitopes within Surface Pneumococcal Virulence Proteins in Pediatric Patients with Invasive Pneumococcal Disease. Lagousi T; Routsias J; Piperi C; Tsakris A; Chrousos G; Theodoridou M; Spoulou V J Biol Chem; 2015 Nov; 290(46):27500-10. PubMed ID: 26396191 [TBL] [Abstract][Full Text] [Related]
3. Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies. Brookes RH; Ming M; Williams K; Hopfer R; Gurunathan S; Gallichan S; Tang M; Ochs MM Hum Vaccin Immunother; 2015; 11(7):1836-9. PubMed ID: 25912273 [TBL] [Abstract][Full Text] [Related]
4. A new candidate epitope-based vaccine against PspA PhtD of Shafaghi M; Bahadori Z; Barzi SM; Afshari E; Madanchi H; Mousavi SF; Shabani AA Front Cell Infect Microbiol; 2023; 13():1271143. PubMed ID: 38035337 [TBL] [Abstract][Full Text] [Related]
5. A bivalent pneumococcal histidine triad protein D-choline-binding protein A vaccine elicits functional antibodies that passively protect mice from Streptococcus pneumoniae challenge. Ochs MM; Williams K; Sheung A; Lheritier P; Visan L; Rouleau N; Proust E; de Montfort A; Tang M; Mari K; Hopfer R; Gallichan S; Brookes RH Hum Vaccin Immunother; 2016 Nov; 12(11):2946-2952. PubMed ID: 27392182 [TBL] [Abstract][Full Text] [Related]
6. L-rhamnose is often an important part of immunodominant epitope for pneumococcal serotype 23F polysaccharide antibodies in human sera immunized with PPV23. Park S; Nahm MH PLoS One; 2013; 8(12):e83810. PubMed ID: 24391831 [TBL] [Abstract][Full Text] [Related]
7. Protective Immune Responses Elicited by Fusion Protein Containing PsaA and PspA Fragments. Lu J; Sun T; Wang D; Dong Y; Xu M; Hou H; Kong FT; Liang C; Gu T; Chen P; Sun S; Lv X; Jiang C; Kong W; Wu Y Immunol Invest; 2015; 44(5):482-96. PubMed ID: 26107747 [TBL] [Abstract][Full Text] [Related]
8. Selection of an immunogenic and protective epitope of the PsaA protein of Streptococcus pneumoniae using a phage display library. Srivastava N; Zeiler JL; Smithson SL; Carlone GM; Ades EW; Sampson JS; Johnson SE; Kieber-Emmons T; Westerink MA Hybridoma; 2000 Feb; 19(1):23-31. PubMed ID: 10768838 [TBL] [Abstract][Full Text] [Related]
9. Development of 5-valent conjugate pneumococcal protein A - Capsular polysaccharide pneumococcal vaccine against invasive pneumococcal disease. Meng C; Lin H; Huang J; Wang H; Cai Q; Fang L; Guo Y Microb Pathog; 2009 Sep; 47(3):151-6. PubMed ID: 19467319 [TBL] [Abstract][Full Text] [Related]
10. Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome lambda-display library. Beghetto E; Gargano N; Ricci S; Garufi G; Peppoloni S; Montagnani F; Oggioni M; Pozzi G; Felici F FEMS Microbiol Lett; 2006 Sep; 262(1):14-21. PubMed ID: 16907734 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of protective immunity responses against pneumococcal PhtD and its C-terminal in combination with outer-membrane vesicles as adjuvants. Malekan M; Siadat SD; Aghasadeghi M; Shahrokhi N; Afrough P; Behrouzi A; Ahmadi K; Mousavi SF J Med Microbiol; 2020 Mar; 69(3):465-477. PubMed ID: 32100705 [No Abstract] [Full Text] [Related]
13. A modified surface killing assay (MSKA) as a functional in vitro assay for identifying protective antibodies against pneumococcal surface protein A (PspA). Genschmer KR; Accavitti-Loper MA; Briles DE Vaccine; 2013 Dec; 32(1):39-47. PubMed ID: 24211169 [TBL] [Abstract][Full Text] [Related]
14. Identification of a human immunodominant B-cell epitope within the immunoglobulin A1 protease of Streptococcus pneumoniae. De Paolis F; Beghetto E; Spadoni A; Montagnani F; Felici F; Oggioni MR; Gargano N BMC Microbiol; 2007 Dec; 7():113. PubMed ID: 18088426 [TBL] [Abstract][Full Text] [Related]
15. Novel Immunoprotective Proteins of Streptococcus pneumoniae Identified by Opsonophagocytosis Killing Screen. Wang Y; Wen Z; Pan X; Briles DE; He Y; Zhang JR Infect Immun; 2018 Sep; 86(9):. PubMed ID: 29891544 [TBL] [Abstract][Full Text] [Related]
16. Correlation between in vitro complement deposition and passive mouse protection of anti-pneumococcal surface protein A monoclonal antibodies. Khan N; Qadri RA; Sehgal D Clin Vaccine Immunol; 2015 Jan; 22(1):99-107. PubMed ID: 25410204 [TBL] [Abstract][Full Text] [Related]
17. Identification of SP1683 as a pneumococcal protein that is protective against nasopharyngeal colonization. Moens L; Hermand P; Wellens T; Wuyts G; Derua R; Waelkens E; Ysebaert C; Godfroid F; Bossuyt X Hum Vaccin Immunother; 2018 May; 14(5):1234-1242. PubMed ID: 29400602 [TBL] [Abstract][Full Text] [Related]
18. Enhanced protection against pneumococcal infection elicited by immunization with the combination of PspA, PspC, and ClpP. Cao J; Chen D; Xu W; Chen T; Xu S; Luo J; Zhao Q; Liu B; Wang D; Zhang X; Shan Y; Yin Y Vaccine; 2007 Jun; 25(27):4996-5005. PubMed ID: 17524530 [TBL] [Abstract][Full Text] [Related]
19. Conjugation of PspA4Pro with Capsular Streptococcus pneumoniae Polysaccharide Serotype 14 Does Not Reduce the Induction of Cross-Reactive Antibodies. da Silva MA; Converso TR; Gonçalves VM; Leite LCC; Tanizaki MM; Barazzone GC Clin Vaccine Immunol; 2017 Aug; 24(8):. PubMed ID: 28637805 [TBL] [Abstract][Full Text] [Related]
20. Antibodies to PcpA and PhtD protect mice against Streptococcus pneumoniae by a macrophage- and complement-dependent mechanism. Visan L; Rouleau N; Proust E; Peyrot L; Donadieu A; Ochs M Hum Vaccin Immunother; 2018 Feb; 14(2):489-494. PubMed ID: 29135332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]